Key Opinion Leaders are members of a community whose advice
is respected by peers and others in their respective fields. Generally, KOLs
are physicians and academicians. However, majority of drug developers choose to
include a range of strategic partners and prefers the term, “experts”. Experts
are mostly experienced physicians, but may include the following like patient
advocacy groups, academics, researchers, and upcoming stars (rising stars:
gained expertise in specific disease area) within therapy area.
Experts/KOLs helps companies understand and identify target
research areas as they are on the front lines of patient care. Also, experts provide
KOL
insights and guidance in each step of drug development process –
clinical trials (influence trial designs); Approvals (advise on regulatory
pathways); Post Approval (builds product awareness in the specialities and
medical community); distribution (experts networks can be leveraged to increase
and spread awareness of new therapy; discuss new findings through scientific
conferences and articles publication).
In short, KOLs help in the following:
- Identifying target customers
- Generate sales
- Enhance companies and products reach
- Increases brand awareness
- Early life-cycle planning
- Conduct RWE studies
No comments:
Post a Comment